Background. Although colony-stimulating factors have been shown to accelerate recovery from severe neutropenia after intensive chemotherapy or bone marrow transplantation, their use in acute leukemia has been controversial because in vitro they stimulate leukemic colonies as well as normal granulocyte colonies. Methods. We conducted a prospective, randomized, controlled study to determine the safety and efficacy of recombinant human granulocyte colony-stimulating factor (CSF) after a standard course of intensive therapy in 108 patients with relapsed or refractory acute leukemia (67 with acute myelogenous leukemia, 30 with acute lymphocytic leukemia, 9 in blast crisis from chronic myelogenous leukemia, and 2 with acute leukemia arising from myelodysplastic syndromes). Treatment with granulocyte CSF (200 micrograms per square meter of body-surface area per day in a 30-minute infusion) was begun two days after the end of the chemotherapy and continued until the neutrophil count rose above 1500 per cubic millimeter. Results. Treatment with granulocyte CSF accelerated the recovery of neutrophils significantly (P less than 0.01), shortening it by about a week, but it had no effect on platelet recovery. Although the incidence of febrile episodes was almost the same, documented infections were significantly less frequent in the group treated with granulocyte CSF (P = 0.028). There was no evidence that granulocyte CSF accelerated the regrowth of leukemic cells. Fifty percent of 48 patients in the CSF group who could be evaluated and 36 percent of 50 controls had complete remission. The rate of relapse was almost the same in the two groups. Conclusions. It appears that recombinant human granulocyte CSF is safe in acute leukemia, accelerating neutrophil recovery and thereby reducing the incidence of documented infection without affecting the regrowth of leukemic cells. It should be used with caution, however, pending further confirmation of these early results.
Source Information
Department of Medicine, Nagoya University Branch Hospital, Japan.
This article has been cited by other articles:
Sung, L., Nathan, P. C., Alibhai, S. M.H., Tomlinson, G. A., Beyene, J.
(2007). Meta-analysis: Effect of Prophylactic Hematopoietic Colony-Stimulating Factors on Mortality and Outcomes of Infection. ANN INTERN MED
147: 400-411
[Abstract][Full Text]
Patte, C., Laplanche, A., Bertozzi, A. I., Baruchel, A., Frappaz, D., Schmitt, C., Mechinaud, F., Nelken, B., Boutard, P., Michon, J.
(2002). Granulocyte Colony-Stimulating Factor in Induction Treatment of Children With Non-Hodgkin's Lymphoma: A Randomized Study of the French Society of Pediatric Oncology. JCO
20: 441-448
[Abstract][Full Text]
Ozer, H., Armitage, J. O., Bennett, C. L., Crawford, J., Demetri, G. D., Pizzo, P. A., Schiffer, C. A., Smith, T. J., Somlo, G., Wade, J. C., Wade, J. L. III, Winn, R. J., Wozniak, A. J., Somerfield, M. R., for the American Society of Clinical Oncology Gro,
(2000). 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines. JCO
18: 3558-3585
[Full Text]
Horikoshi, Y., Mimaya, J.-i., Amano, K., Kawano, Y., Watanabe, A., Watanabe, T., Sekine, I., Nishikawa, K., Tsunematsu, Y., Endo, M., Eguchi, H., Koyama, T., Kawakami, K., Oka, T., Matsushita, T., Koizumi, S., Fujimoto, T., Takaue, Y.
(2000). Feasibility Study of Autologous Peripheral Blood Stem Cell Transplantation for the Treatment of Childhood Acute Myelogenous Leukemia. Jpn J Clin Oncol
30: 137-145
[Abstract][Full Text]
Hiddemann, W., Kern, W., Schoch, C., Fonatsch, C., Heinecke, A., Wormann, B., Buchner, T.
(1999). Management of Acute Myeloid Leukemia in Elderly Patients. JCO
17: 3569-3576
[Abstract][Full Text]
Marina, N. M., Pappo, A. S., Parham, D. M., Cain, A. M., Rao, B. N., Poquette, C. A., Pratt, C. B., Greenwald, C., Meyer, W. H.
(1999). Chemotherapy Dose-Intensification for Pediatric Patients With Ewing's Family of Tumors and Desmoplastic Small Round-Cell Tumors: A Feasibility Study at St. Jude Children's Research Hospital. JCO
17: 180-180
[Abstract][Full Text]
Godwin, J. E., Kopecky, K. J., Head, D. R., Willman, C. L., Leith, C. P., Hynes, H. E., Balcerzak, S. P., Appelbaum, F. R.
(1998). A Double-Blind Placebo-Controlled Trial of Granulocyte Colony-Stimulating Factor in Elderly Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study (9031). Blood
91: 3607-3615
[Abstract][Full Text]
Witz, F., Sadoun, A., Perrin, M.-C., Berthou, C., Briere, J., Cahn, J.-Y., Lioure, B., Witz, B., Francois, S., Desablens, B., Pignon, B., Le Prise, P.-Y., Audhuy, B., Caillot, D., Casassus, P., Delain, M., Christian, B., Tellier, Z., Polin, V., Hurteloup, P., Harousseau, J.-L.
(1998). A Placebo-Controlled Study of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Administered During and After Induction Treatment for De Novo Acute Myelogenous Leukemia in Elderly Patients. Blood
91: 2722-2730
[Abstract][Full Text]
Heil, G., Hoelzer, D., Sanz, M. A., Lechner, K., Liu Yin, J. A., Papa, G., Noens, L., Szer, J., Ganser, A., O'Brien, C., Matcham, J., Barge, A.
(1997). A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia. Blood
90: 4710-4718
[Abstract][Full Text]
Talcott, J. A.
(1997). Outpatient Management of Febrile Neutropenia: Should We Change the Standard of Care?. The Oncologist
2: 365-373
[Abstract][Full Text]
Rowe, J. M., Tallman, M. S.
(1997). Intensifying Induction Therapy in Acute Myeloid Leukemia: Has a New Standard of Care Emerged?. Blood
90: 2121-2126
[Full Text]
Geissler, K., Koller, E., Hubmann, E., Niederwieser, D., Hinterberger, W., Geissler, D., Kyrle, P., Knobl, P., Pabinger, I., Thalhammer, R., Schwarzinger, I., Mannhalter, C., Jaeger, U., Heinz, R., Linkesch, W., Lechner, K.
(1997). Granulocyte Colony-Stimulating Factor as an Adjunct to Induction Chemotherapy for Adult Acute Lymphoblastic Leukemia --- A Randomized Phase-III Study. Blood
90: 590-596
[Abstract][Full Text]
Hartmann, L. C., Tschetter, L. K., Habermann, T. M., Ebbert, L. P., Johnson, P. S., Mailliard, J. A., Levitt, R., Suman, V. J., Witzig, T. E., Wieand, H.S., Miller, L. L., Moertel, C. G., Grendahl, D. C., Herrera, D. M.
(1997). Granulocyte Colony-Stimulating Factor in Severe Chemotherapy-Induced Afebrile Neutropenia. NEJM
336: 1776-1780
[Abstract][Full Text]
Pui, C.-H., Boyett, J. M., Hughes, W. T., Rivera, G. K., Hancock, M. L., Sandlund, J. T., Synold, T., Relling, M. V., Ribeiro, R. C., Crist, W. M., Evans, W. E.
(1997). Human Granulocyte Colony-Stimulating Factor after Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia. NEJM
336: 1781-1787
[Abstract][Full Text]
Moore, J. O., Dodge, R. K., Amrein, P. C., Kolitz, J., Lee, E. J., Powell, B., Godfrey, S., Robert, F., Schiffer, C. A.
(1997). Granulocyte Colony-Stimulating Factor (Filgrastim) Accelerates Granulocyte Recovery After Intensive Postremission Chemotherapy for Acute Myeloid Leukemia With Aziridinyl Benzoquinone and Mitoxantrone: Cancer and Leukemia Group B Study 9022 . Blood
89: 780-788
[Abstract][Full Text]
Dombret, H., Chastang, C., Fenaux, P., Reiffers, J., Bordessoule, D., Bouabdallah, R., Mandelli, F., Ferrant, A., Auzanneau, G., Tilly, H., Yver, A., Degos, L., The AML Cooperative Study Group,
(1995). A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous Leukemia. NEJM
332: 1678-1683
[Abstract][Full Text]
Previous
